Senores Pharma appoints Jignesh Desai as President - Finance

Published On 2025-06-23 09:28 GMT   |   Update On 2025-06-23 09:36 GMT

AhmedabadSenores Pharma has appointed Jignesh Desai as the President - Finance.

"We’re excited to welcome Mr. Jignesh Desai as the President – Finance at Senores Pharmaceuticals," Senores informed in a Linkedin post.
With almost 30 years of experience across leading pharma and manufacturing companies, Desai brings deep expertise in corporate finance, budgeting, internal audits, cost control and regulatory compliance.
A qualified Cost & Management Accountant and ICAI member, he will play a key role in driving financial strategy and operational efficiency at Senores.
Prior to Senores, Desai held various leadership positions at Cadila Pharma, including AVP – Finance and President – PurchaseHis career also includes key roles at Zydus Cadila and Gokul Refoils & Solvents Ltd.

Senores Pharmaceuticals Limited is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms. The companies’ current portfolio includes 61 ANDA and 22 CMO/CDMO commercial products that are permitted for distribution in the USA. Senores is also engaged in the development and manufacturing of complex generics certified by global food and drugs authorities and delivers generic drugs for emerging markets, catering to more than 40 countries. The company currently has approval from regulatory bodies of more than 10 countries for its manufacturing facility in Chhatral for emerging markets with over 280 product registrations and 630 product applications. Senores also manufactures critical care injectables and Active Pharmaceutical Ingredients (“API”). Senores has 2 manufacturing facilities for formulations – one in Atlanta, US which is USFDA approved and DEA, TAA & BAA compliant for controlled substances and government supplies & other is in Chhatral, Ahmedabad, India approved by WHO-GMP to cater to emerging markets. The company also has 2 manufacturing facilities for API in India, both located around Ahmedabad, with one in Chhatral and the other in Naroda.

Read also: Senores Pharma buys USFDA approved Tramadol Tablets from APDM Pharma



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News